Cargando…
Exploring the Molecular Mechanism of Qing Guang An Granule in Treating Glaucoma Using Network Pharmacology and Molecular Docking
BACKGROUND: Qing Guang An Granule (QGAG), a Chinese patent medicine, has been used clinically to treat glaucoma for more than 20 years. OBJECTIVE: To explore the possible mechanism of treatment of QGAG in glaucoma by using network pharmacology and molecular docking in this study. METHODS: Active com...
Autores principales: | Ou, Chen, Song, Houpan, Zhou, Yasha, Peng, Jun, Peng, Qinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704137/ https://www.ncbi.nlm.nih.gov/pubmed/33299458 http://dx.doi.org/10.1155/2020/8824150 |
Ejemplares similares
-
The mechanism of the Shuang Bai Su Qing recipe in treating periodontitis based on network pharmacology and molecular docking technology
por: Zhang, Haomin, et al.
Publicado: (2023) -
Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review
por: Hou, Yuan, et al.
Publicado: (2023) -
Analysis of mechanisms of Shenhuang Granule in treating severe COVID-19 based on network pharmacology and molecular docking
por: Xu, Xiang-ru, et al.
Publicado: (2022) -
Qing-Yi Decoction in the Treatment of Acute Pancreatitis: An Integrated Approach Based on Chemical Profile, Network Pharmacology, Molecular Docking and Experimental Evaluation
por: Wei, Tian-Fu, et al.
Publicado: (2021) -
Network pharmacology, molecular docking, and experimental validation to explore the potential mechanism of Long Mu Qing Xin mixture for the treatment of attention deficit hyperactivity disorder
por: Li, Xuejun, et al.
Publicado: (2023)